Answers are grounded in this paper and cite their sources.
Understanding disparities in COVID-19 preventive efforts among underserved populations requires a holistic approach that considers multiple social determinants of health (SDOH). While disparities in individual COVID-19 risk factors are well-documented, the cumulative impact of these factors on vaccine uptake and testing remains insufficiently quantified. This study applies a polysocial risk framework to assess the combined influence of geo-demographic, economic, and health-related factors on COVID-19 vaccination and testing. Using cross-sectional data from 9,758 participants enrolled in the NIH Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP) program (February 2020-April 2023), we analyzed associations between polysocial risk and preventive behaviors using multivariable generalized estimating equations (GEE). Overall, 72.5% of participants reported COVID-19 vaccination, and 82.1% reported testing. However, disparities were evident across polysocial risk profiles. Individuals experiencing intersecting geo-demographic (Non-Hispanic Black, age 45, Southern residence), economic (low education, unemployment, financial hardship), and health-related risk factors (substance use, low CVD risk, no flu vaccination) were 43-48 percentage points less likely to be vaccinated compared to groups with higher adoption (p < 0.001). Testing disparities were narrower but remained significant, with differences ranging from 2 to 27 percentage points depending on the specific polysocial risk profiles. The findings underscore the utility of polysocial risk modeling as a predictive tool for identifying populations at highest risk of disengagement from preventive care, informing targeted precision public health interventions. Beyond COVID-19, this approach has broader applicability for understanding disparities in chronic disease prevention, cancer screening, maternal and child health, and health-related social needs (HRSN) interventions. Integrating polysocial risk assessments into clinical and public health settings can enhance data-driven strategies to improve population health outcomes.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: